CEDIMBA - DIM Clínica Privada - Buenos Aires
Con más de 18 años de experiencia, CEDIMBA es uno de los centros de investigación más activos en la producción de trabajos clínicos de investigación, habiendo gestionado y coordinado más de 160 protocolos en colaboración con la industria farmacéutica. Contamos con un equipo de profesionales procedente de todas las especialidades médicas, moderna infraestructura y tecnología de vanguardia.Belgrano 136, Ramos Mejia, Buenos Aires.
Websitehttp://dim.com.ar/cedimba
Select an option
I am a doctor
I am a sponsor
Our team
Medical staff
Soledad Perez
Juan Manuel Couceiro
Ana Lucia Acosta
Lara Grosso
Micaela De Agustini
Oscar Romano Montaña PI
Alejandra Mabel Camino
Cecilia Vitale
Silvina Alba
Fabiana Aprile
Jeannine Montaña
Gustavo Braslavsky
Oscar Romano Montaña
Analía Simcic
Liliana Esposito
Gloria Cendali
Micaela Soria
Open studies
Cardiovascular disease
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - ATTAIN-Outcomes - Eli Lilly and CompanySee more
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
Obesity
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity - MARITIME-CV - AmgenSee more
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity - MARITIME-HF - AmgenSee more
A Study of Tirzepatide in Adolescents With Obesity and Weight-Related Comorbidities (SURMOUNT-ADOLESCENTS-2) - SURMOUNT-ADOLESCENTS-2 - Eli Lilly and CompanySee more
Steatohepatitis
LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis - LIVERAGE - Boehringer IngelheimSee more
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis - LIVERAGE - Cirrosis - Boehringer IngelheimSee more
Renal disease
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes) - ATTAIN-Outcomes - Eli Lilly and CompanySee more
Elevated Lipoprotein A
Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) - MOVE-Lp(a) - Eli Lilly and CompanySee more
Heart failure
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity - MARITIME-HF - AmgenSee more
Cirrhosis
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis - LIVERAGE - Cirrosis - Boehringer IngelheimSee more
